Release date: 2024-07-10 14:07:34 Recommended: 199

Larotinib is the first specific targeting drug in the world that only targets a certain tumor regardless of tumor type. It can be used for 17 kinds of tumors, including breast cancer, colorectal cancer, lung cancer, thyroid, etc. Even if conventional therapy is ineffective, corresponding genes can be found through NTRK gene detection, which has a quick effect and a long acting time, and is suitable for adults and children.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended:475Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended:475Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended:535Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended:414Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended:612Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended:401Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:570Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:481Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended:261Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended:266Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended:276Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended:256Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended:302Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended:261Release date: 2025-12-01